Floatz logo

Von Willebrand Factor

Von Willebrand's Disease

National Center for Research Resources (NCRR)protein_peptidePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Von Willebrand's Disease cohort.

Asset / SponsorPhaseRating
Alphanate Sd/Ht
Grifols Biologicals, LLC
Phase 4BB
FACTOR VIII (HUMAN)
Bio Products Laboratory
Phase 3BB
INTERLEUKIN-11
University of Pittsburgh
Phase 2B
Oprelvekin
University of Pittsburgh
Phase 2CCC
Tranexamic Acid
Assiut University
D
HUMAN ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX
Assiut University
D
Rondaptivon pegol sodium
Medical University of Vienna
Phase 2NR
Cyclokapron
Mary M. Gooley Hemophilia Center
N/ANR

Same molecule, other indications

Von Willebrand Factor is also rated in:

von Willebrand disease 3Dormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →